Small doses of remifentanil plus propofol-etomidate anesthesia in painless gastroscopy of adult
-
摘要:
目的 探讨小剂量瑞芬太尼复合丙泊酚-依托咪酯麻醉在成人无痛胃镜中的效果及不良反应。 方法 将300例拟行无痛胃镜检查的成人患者,随机分成3组:小剂量瑞芬太尼复合丙泊酚组(P组)、小剂量瑞芬太尼复合依托咪酯组(E组)、小剂量瑞芬太尼复合丙泊酚-依托咪酯组(PE组)。P组先缓慢静注小剂量瑞芬太尼0.5 μg/kg后,再缓慢推注丙泊酚1 mg/kg,待患者入睡,睫毛反射消失后行胃镜检查,必要时可单次追加丙泊酚20~30 mg。E组缓慢推注依托咪酯0.2 mg/kg,必要时单次追加4~6 mg,PE组缓慢推注丙泊酚0.5 mg/kg+依托咪酯0.1 mg/kg,必要时单次追加丙泊酚10~15 mg+依托咪酯2~3 mg,其他同P组。记录患者用药后起效时间、检查持续时间、患者苏醒时间、离开复苏室时间;麻醉前、入镜时、入镜后2 min、出镜时的收缩压;舒张压;心率;血氧饱和度;记录注射痛、肌颤、呕吐等不良事件,分别评定麻醉效果。 结果 PE组、P组患者的苏醒时间及离开复苏室时间快于E组(P<0.05);PE组和E组患者入镜时、入镜后2 min、出镜时与麻醉前比较,收缩压、舒张压、心率、血氧饱和度差异无统计学意义;P组入镜时、入镜后2 min、出镜时的收缩压、舒张压、心率要明显低于麻醉前的指标,差异具有统计学定义(P<0.05);入镜时、入镜后2 min的血氧饱和度低于麻醉前(P<0.05);PE组检查过程中没有发生肌颤的患者,体动、需追加药物的患者及注射痛、心动过缓、低血压、缺氧等不良事件少于P组(P<0.05);PE组麻醉效果满意度整体优于P组和E组。 结论 小剂量瑞芬太尼复合丙泊酚-依托咪酯麻醉用于成人无痛胃镜检查安全可行,麻醉效果满意,能有效减少注射痛、呼吸循环抑制、肌颤等不良事件,值得临床上推广应用。 Abstract:Objective To explore the feasibility of small doses of remifentanil plus propofol -etomidate anesthesia in adult painless gastroscopy, and observe the effect and adverse reactions. Methods A total of 300 adult patients of awaiting painless gastroscopy were randomly divided into 3 groups : small doses of remifentanil plus propofol (P group), small doses of remifentanil plus etomidate (E group), and small doses of remifentanil plus Propofol -Etomidate (PE group). Induction time, duration time, recovery time, time to leave recovery room and SBP, DBP,HR, SpO2 in T0 (prior to anesthesia), T1 (at the time point of undergoing gastroscopy), T2 (2 minutes after the gastroscopy), T3 (at the time point of finished gastroscopy) were observed. Injection pain, muscular fibrillation, nausea and vomit, additional drugs were recorded to evaluate the anesthesia effect. Results Recovery time and time to leave recovery room of PE group and E group were shorter time. Among PE group and E group, differences of SBP, DBP,HR, SpO2 btween the T1, T2, T3 and the T0 were not significant (P>0.05). Incidence of injection pain, muscular fibrillation, nausea and vomit and additional drugs in PE group were lower (P<0.05). Satisfaction of anesthetist and gastroscopist with EP group was higher than that of P group (P<0.05). Conclusion Small doses of remifentanil plus propofol-etomidate anesthesia in adult painless gastroscopy is safe and satisfactory with a lower incidence of adverse reactions.It has a higher satisfaction of anesthetist and gastroscopist. -
Key words:
- painless gastroscopy /
- remifentanil /
- etomidate /
- propofol
-
表 1 3组患者一般资料比较(n=100)
项目 P组 E组 PE组 性别(n,男/女) 68/32 66/34 70/30 年龄(Mean±SD,岁) 46.05±11.20 45.87±12.43 46.39±13.78 体质量指数(Mean±SD,kg/m2) 21.37±3.16 20.89±2.69 21.13±2.95 基础SBP(Mean±SD,mmHg) 138.21±21.25 137.89±24.32 139.07±20.87 基础DBP(Mean±SD,mmHg) 82.95±9.58 83.21±8.87 84.01±10.04 基础HR(Mean±SD,次/min) 78.35±15.48 76.52±12.69 76.88±13.57 基础SpO2(Mean±SD,%) 98.05±1.04 97.97±1.63 98.03±1.52 ASA分级(n,%) ASAⅠ 27(27.00%) 30(30.00%) 26(26.00%) ASAⅡ 53(53.00%) 49(49.00%) 55(55.00%) ASAⅢ 20(20.00%) 21(21.00%) 19(19.00%) 3组比较, P均>0.05; SBP: 收缩压; DBP: 舒张压; HR: 心率; SpO2: 血氧饱和度; P组: 小剂量瑞芬太尼复合丙泊酚组; E组: 小剂量瑞芬太尼复合依托咪酯组; PE组: 小剂量瑞芬太尼复合丙泊酚-依托咪酯组. 表 2 3组患者用药后起效时间、检查持续时间、患者苏醒时间、离开复苏室时间比较(Mean±SD,n=100,s)
时间 P组 E组 PE组 用药后起效 68.78±10.31 66.96±12.46 68.64±13.05 检查持续 278.65±89.47 284.65±93.12 282.65±88.81 患者苏醒 408.83±135.42△ 464.79±155.38 421.47±138.65△ 离开复苏室 1135.76±183.37△ 1302.76±198.89 1102.03±191.54△ △P<0.05vs E组; P组: 小剂量瑞芬太尼复合丙泊酚组; E组: 小剂量瑞芬太尼复合依托咪酯组; PE组: 小剂量瑞芬太尼复合丙泊酚-依托咪酯组. 表 3 3组患者在T0、T1、T2、T3时间点SBP、DBP、HR、SpO2变化的比较(Mean±SD)
时间 组别(n=100) SBP(mmHg) DBP(mmHg) HR(次/min) SpO2(%) T0 P组 138.21±21.25 82.95±9.58 78.35±15.48 98.05±1.04 E组 137.89±24.32 83.21±8.87 76.52±12.69 97.97±1.63 PE组 139.07±20.87 84.01±10.04 76.88±13.57 98.03±1.52 T1 P组 102.14±35.52* 70.25±12.67* 64.72±18.68* 91.25±3.62* E组 128.75±28.87 80.21±10.72 71.95±13.89 96.82±2.12 PE组 129.86±22.82 80.81±12.64 74.18±16.58 97.03±1.82 T2 P组 101.02±37.46* 68.79±13.58* 61.84±16.51* 90.03±5.41* E组 130.79±26.43 81.12±9.25 73.44±10.80 95.97±1.03 PE组 130.21±27.69 81.90±15.02 74.97±15.43 96.93±2.25 T3 P组 113.58±39.72* 69.46±11.75* 65.29±15.49* 97.53±1.43 E组 131.02±27.25 81.78±9.03 74.88±11.41 99.43±1.05 PE组 132.88±28.07 82.15±9.64 75.05±12.50 99.53±1.02 *P<0.05vs T0; SBP: 收缩压; DBP: 舒张压; HR: 心率; SpO2: 血氧饱和度; P组: 小剂量瑞芬太尼复合丙泊酚组; E组: 小剂量瑞芬太尼复合依托咪酯组; PE组: 小剂量瑞芬太尼复合丙泊酚-依托咪酯组; T0: 麻醉前; T1: 入镜时; T2: 入镜后2 min; T3: 出镜时. 表 4 3组患者相关不良事件、并发症及处理比较[n=100,n(%)]
项目 P组 E组 PE组 注射痛 38(38.00) 5(5.00)* 7(7.00)* 体动 23(23.00) 11(11.00)* 8(8.00)* 肌颤 0(0.00)* 9(9.00) 0(0.00)* 恶心呕吐 0(0.00) 1(1.00) 0(0.00) 心动过缓 11(11.00) 3(3.00)* 1(1.00)* 低血压 26(26.00) 2(2.00)* 5(5.00)* 轻度缺氧 25(25.00) 18(18.00)* 13(13.00)* 严重缺氧 8(8.00) 1(1.00)* 0(0.00)* 追加药物的患者 18(18.00) 7(7.00)* 5(5.00)* 使用活血管药物患者 0(0.00) 0(0.00) 0(0.00) 缺氧需提下颌的患者 8(8.00) 1(1.00)* 0(0.00)* 缺氧需面罩给氧患者 0(0.00) 0(0.00) 0(0.00) *P<0.05vs P组; ▼P<0.05vs E组; P组: 小剂量瑞芬太尼复合丙泊酚组; E组: 小剂量瑞芬太尼复合依托咪酯组; PE组: 小剂量瑞芬太尼复合丙泊酚-依托咪酯组. 表 5 3组患者麻醉效果满意度比较[n=100,n(%)]
对象 满意度 P组 E组 PE组 麻醉医师 满意 58(58.00) 53(53.00) 94(94.00)* 比较满意 30(30.00) 39(39.00) 5(5.00) 不满意 12(12.00) 8(8.00) 1(1.00)*★ 消化内镜医师 满意 73(73.00) 81(81.00) 97(97.00)* 比较满意 18(18.00) 19(19.00) 3(3.00) 不满意 9(9.00) 0(0.00) 0(0.00)★ 患者本人 满意 89(89.00) 97(97.00) 95(95.00) 比较满意 11(11.00) 3(3.00) 5(5.00) 不满意 0(0.00) 0(0.00) 0(0.00) *P<0.05vs P组、E组; ★P<0.05vs P组; P组: 小剂量瑞芬太尼复合丙泊酚组; E组: 小剂量瑞芬太尼复合依托咪酯组; PE组: 小剂量瑞芬太尼复合丙泊酚-依托咪酯组. -
[1] 中华医学会麻醉学分会. 中华医学会消化内镜学分会.中国消化内镜诊疗镇静/麻醉的专家共识[J]. 临床麻醉学杂志, 2014,24(09): 920-7. https://www.wenkuxiazai.com/doc/efb66123770bf78a6429546f.html [2] Leslie K, Allen ML, Hessian E, et al. Survey of anaesthetists' practice of sedation for gastrointestinal endoscopy[J]. Anaesth Intens Care, 2016, 44(4): 491-7. https://www.researchgate.net/publication/306147021_Survey_of_anaesthetists'_practice_of_sedation_for_gastrointestinal_endoscopy [3] Xu ZY, Wang X, Si YY, et al. Intravenous remifentanil and propofol for gastroscopy[J]. J Clin Anesth, 2008, 20(5): 352-5. doi: 10.1016/j.jclinane.2008.03.006 [4] Gholipour BA, Firouzian A, Zamani KA, et al. Effect of etomidate versus combination of Propofol-Ketamine and Thiopental-Ketamine on hemodynamic response to laryngoscopy and intubation:a randomized double blind clinical trial[J]. Anesthesiol Pain Med, 2016, 6(1): e30071-4. https://www.researchgate.net/publication/287151214_Effect_of_Etomidate_Versus_Combination_of_Propofol-Ketamine_and_Thiopental-Ketamine_on_Hemodynamic_Response_to_Laryngoscopy_and_Intubation_A_Randomized_Double_Blind_Clinical_Trial [5] Wang L, Li W, Xu R, et al. Meta analysis for the anesthesia effect and adverse reactions of etomidate and propofol on the painless abortion surgery[J]. J Central South Univ Med Sci, 2016, 41(4): 427-33. http://industry.wanfangdata.com.cn/dl/Detail/Periodical?id=Periodical_hnykdx201604015 [6] Wang C, Liu N, Li RM, et al. Effects of propofol and etomidate pretreatment on glucocorticoid receptor expression following induction of sepsis in rats[J]. Genetic Molecul Res, 2015, 14 (2): 4740-8. [7] Xiao DH, Shen SR, Xu CX, et al. Effect of various uses of propofol on the upper gastrointestinal endoscopy[J]. J Central South Univ Med Sci, 2007, 32 (3): 443-6. [8] 张艳丽, 张东亚. 无痛胃镜不同入镜时点丙泊酚联合舒芬太尼静脉麻醉效果的比较[J]. 临床麻醉学杂志, 2016,12(6): 573-5.Ref [9] 田首元,汪祖巾,刘保江. 丙泊酚麻醉用于无痛胃镜检查的剂量探讨[J]. 临床麻醉学杂志, 2007, 24(8):739-41.Ref [10] Numazaki M, Fujii Y. Antiemetic efficacy of propofol at small doses for reducing nausea and vomiting following thyroidectomy[J]. Can J Anaesth, 2005, 52(3): 333-4. doi: 10.1007/s12630-013-9940-8 [11] Gasparovic S, Rustemovic N, Opacic M, et al. Clinical analysis of propofol deep sedation for 1,104 patients undergoing gastrointestinal endoscopic procedures:a three year prospective study[J]. World J Gastroenterol, 2006, 12(2): 327-30. doi: 10.3748/wjg.v12.i2.327 [12] Stokes DN, Hutton P. Rate-dependent induction phenomena with propofol:implications for the relative potency of intravenous anesthetics[J]. Anesth Analg, 1991, 72(5): 578-83. https://www.researchgate.net/publication/21138224_Rate-Dependent_Induction_Phenomena_With_Propofol_Implications_for_the_Relative_Potency_of_Intravenous_Anesthetics [13] Uzun S, Goezacan A, Canbay O, et al. Remifentanil and etomidate for laryngeal mask airway insertion[J]. J Int Med Res, 2007, 35(6): 878-85. doi: 10.1177/147323000703500616 [14] Shen XC, Ao X, Cao Y, et al. Etomidate-Remifentanil is more suitable for monitored anesthesia care during gastroscopy in older patients than Propofol-Remifentanil[J]. Med Sci Monit, 2015, 21(7): 1-8. https://www.researchgate.net/publication/270656135_Etomidate-Remifentanil_is_more_Suitable_for_Monitored_Anesthesia_Care_during_Gastroscopy_in_Older_Patients_than_Propofol-Remifentanil [15] Shah SB, Chowdhury I, Bhargava AK, et al. Comparison of hemodynamic effects of intravenous etomidate versus propofol during induction and intubation using entropy guided hypnosis levels[J]. J Anaesthesiol Clin Pharmacol, 2015, 31(2): 180-5. doi: 10.4103/0970-9185.155145 [16] Yagan O, Tas N, Kucuk A, et al. Haemodynamic responses to tracheal intubation using propofol,etomidate and Etomidate-Propofol combination in anaesthesia induction[J]. J Cardiovasc Thoracic Res, 2015, 7(4): 134-40. doi: 10.15171/jcvtr.2015.30 [17] Aggarwal S, Goyal VK, Chaturvedi SK, et al. A comparative study between propofol and etomidate in patients under general anesthesia[J]. Rev Bras Anestesiol, 2016, 66(3): 237-41. doi: 10.1016/j.bjan.2016.02.010 [18] Du Y, Chen YJ, He B, et al. The effects of Single-Dose etomidate versus propofol on cortisol levels in pediatric patients undergoing urologic surgery: a randomized controlled trial[J]. Anesth Analg, 2015, 121(6): 1580-5. doi: 10.1213/ANE.0000000000000981 [19] Zhou X, Li BX, Chen LM, et al. Etomidate plus propofol versus propofol alone for sedation during gastroscopy: a randomized prospective clinical trial[J]. Surg Endosc, 2016, 30(11): 5108-16. doi: 10.1007/s00464-016-4861-6 [20] Kaushal RP, Vatal A, Pathak R. Effect of etomidate and propofol induction on hemodynamic and endocrine response in patients undergoing coronary artery bypass grafting/mitral valve and aortic valve replacement surgery on cardiopulmonary bypass[J]. Ann Card Anaesth, 2015, 18(2): 172-8. doi: 10.4103/0971-9784.154470 [21] Babateen O, Jin Z, Bhandage AK, et al. Etomidate, propofol and diazepam potentiate GABA-evoked GABA(A) currents in a cell line derived from human glioblastoma[J]. Eur J Pharmacol, 2015, 74(8): 101-7. https://www.deepdyve.com/lp/elsevier/etomidate-propofol-and-diazepam-potentiate-gaba-evoked-gaba-a-currents-700vsZ0tqD
计量
- 文章访问数: 703
- HTML全文浏览量: 277
- PDF下载量: 10
- 被引次数: 0